These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3219572)

  • 1. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K; Shibata R
    Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate actions on mesocortical dopamine metabolism in the rat.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1986 Nov; 39(21):2033-6. PubMed ID: 3784768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin on acetylcholine turnover and dopamine release in the rat striatum and cortex.
    Cosi C; Altar AC; Wood PL
    Eur J Pharmacol; 1989 Jun; 165(2-3):209-14. PubMed ID: 2776829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA; Boyar WC
    Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA; Sedvall G
    Eur J Pharmacol; 1975 Feb; 30(2):364-7. PubMed ID: 236193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the origin of striatal cholecystokinin release: studies with in vivo microdialysis.
    You ZB; Herrera-Marschitz M; Brodin E; Meana JJ; Morino P; Hökfelt T; Silveira R; Goiny M; Ungerstedt U
    J Neurochem; 1994 Jan; 62(1):76-85. PubMed ID: 7903356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB; Strupish J; Nahorski SR
    Brain Res; 1986 Apr; 370(2):310-4. PubMed ID: 3708329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral neurochemical changes induced by unilateral cerebral haloperidol administration: evidence for cerebral asymmetry in the rat.
    Hyde JF; Jerussi TP
    Pharmacol Biochem Behav; 1992 Jul; 42(3):457-64. PubMed ID: 1409779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.
    Tanganelli S; Fuxe K; von Euler G; Eneroth P; Agnati LF; Ungerstedt U
    J Neural Transm Gen Sect; 1990; 81(3):183-94. PubMed ID: 2397084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
    Mefford IN; Roth KA; Agren H; Barchas JD
    Brain Res; 1988 Dec; 475(2):380-4. PubMed ID: 2905626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1986; 43(5):590-6. PubMed ID: 3528901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.